Toft-Petersen, MarieNederby, LineKjeldsen, EigilKerndrup, Gitte BBrown, Gordon DHokland, PeterStidsholt Roug, Anne2016-11-242016-11-242016-11Toft-Petersen, M, Nederby, L, Kjeldsen, E, Kerndrup, G B, Brown, G D, Hokland, P & Stidsholt Roug, A 2016, 'Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome', British Journal of Haematology, vol. 175, no. 3, pp. 393-401. https://doi.org/10.1111/bjh.142700007-1048http://hdl.handle.net/2164/7739Acknowledgements The authors would like to thank Petter S. Woll, MSc, PhD, Karolinska Institutet, Stockholm, Sweden, for the kind and generous supervision of the LTC-IC experiments. We thank the FACS Core Facility at Aarhus University for access to the cell sorter and Pia S. Kristensen, Department of Haematology, Aarhus University Hospital for her excellent technical assistance conducting the FISH experiments. The Karen Elise Jensen Foundation, The Meyer Foundation, The Wellcome Trust and the Danish Cancer Society supported the study.9392432engSDG 3 - Good Health and Well-beingcancer stem cellsmyelodysplastic syndromehMICLCD371LTC-ICR MedicineWellcome TrustRJournal article10.1111/bjh.142701753